4/A
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-000294
Options or other derivatives
- Pres. Research & Development acquired 186,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Young David Pres. Research & Development | 2025-01-29 | Grant or award · Warrants | +124,500 | 124,500 | D | ||
| Young David Pres. Research & Development | 2025-01-29 | Grant or award · Warrants | +62,250 | 62,250 | D | ||
Loading xslF345X05/form4.xml…